SCHEMBL8867993

SCHEMBL8867993

CCOCCNC(=O)c1ccc(S(=O)(=O)NC(=O)c2ccc(C(=O)NCC(=O)OCC)nc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 3/20 0.46
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
EGFR P00533 2/20 0.42
POLB P06746 1/20 0.41
TDP1 Q9NUW8 1/20 0.39
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
CA2 P00918 1/20 0.39
HPGD P15428 3/20 0.38
FLT1 P17948 1/20 0.38
FLT4 P35916 1/20 0.38
KDR P35968 1/20 0.38
RXFP1 Q9HBX9 1/20 0.37
TP53 P04637 1/20 0.37
GLA P06280 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8868825 0.95 HPGD (0.46) P4HTMNPC1RAB9ASMN1; SMN2EGFR
SCHEMBL8869141 0.95 P4HTM (0.45) P4HTMNPC1RAB9ASMN1; SMN2EGFR
SCHEMBL8868530 0.94 P4HTM (0.49) P4HTMNPC1RAB9ASMN1; SMN2EGFR
SCHEMBL8869447 0.94 P4HTM (0.49) P4HTMNPC1RAB9ASMN1; SMN2EGFR
SCHEMBL8869631 0.92 P4HTM (0.53) P4HTMNPC1RAB9ASMN1; SMN2EGFR
SCHEMBL8869780 0.91 P4HTM (0.46) P4HTMRAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL8868438 0.91 P4HTM (0.48) P4HTMNPC1RAB9ASMN1; SMN2EGFR
SCHEMBL8869146 0.90 P4HTM (0.44) P4HTMNPC1RAB9ASMN1; SMN2EGFR
SCHEMBL8868007 0.90 P4HTM (0.47) P4HTMNPC1RAB9ASMN1; SMN2EGFR
SCHEMBL8868726 0.89 P4HTM (0.50) P4HTMNPC1RAB9ASMN1; SMN2EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed